One-year results of switching to aflibercept for persistent diabetic macular edema resistant to bevacizumab

One-year results of switching to aflibercept for persistent diabetic macular edema resistant to bevacizumab

PURPOSE: The aim of this study is to evaluate the functional and anatomical effects of switching from bevacizumab to aflibercept in patients with persistent diabetic macular edema (DME) resistant to bevacizumab. MATERIALS AND METHODS: Patients with DME refractory to bevacizumab (1.25 mg/0.05 mL) wer...

Full description

Bibliographic Details
Main Authors: Mahmoud Alaa Abouhussein, Amir Ramadan Gomaa
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Taiwan Journal of Ophthalmology
Subjects:
aflibercept
bevacizumab
diabetic macular edema
intravitreal injection
Online Access:http://www.e-tjo.org/article.asp?issn=2211-5056;year=2021;volume=11;issue=3;spage=266;epage=272;aulast=Abouhussein

Internet

http://www.e-tjo.org/article.asp?issn=2211-5056;year=2021;volume=11;issue=3;spage=266;epage=272;aulast=Abouhussein

Similar Items